CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis

Human Molecular Genetics

Volumn 19, Issue 11, 2010, Pages 2331-2340

  Bronson, Paola G ^a   Caillier, Stacy ^b   Ramsay, Patricia P ^a   McCauley, Jacob L ^c   Zuvich, Rebecca L ^d   De Jager, Philip L ^e,f   Rioux, John D ^g   Ivinson, Adrian J ^h   Compston, Alastair ⁱ   Hafler, David A ^f,j   Sawcer, Stephen J ⁱ   Pericak Vance, Margaret A ^c   Haines, Jonathan L ^d   Hauser, Stephen L ^b   Oksenberg, Jorge R ^b   Barcellos, Lisa F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g MONTREAL HEART INSTITUTE   (Canada)

^h The Harvard Center for Neurodegeneration & Repair   (United States)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; C TYPE LECTIN DOMAIN FAMILY 16 A PROTEIN; CYTOSINE; GENE PRODUCT; GUANINE; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS II TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HLA DRB1 ANTIGEN; HLA-DRB1*15:01 ANTIGEN; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ANTIGEN PRESENTATION; GENETICS; METABOLISM; RISK FACTOR; STATISTICAL MODEL;

ANTIGEN PRESENTATION; GENETIC VARIATION; HLA-DR ANTIGENS; HLA-DRB1 CHAINS; HUMANS; LOGISTIC MODELS; MULTIPLE SCLEROSIS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANS-ACTIVATORS;

EID: 77953576852     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq101     Document Type: Article

References (76)

1. Hauser, S.L. and Goodin, D.S. (2005) Multiple sclerosis and other demyelinating diseases. Kasper, D.L., Braunwald, E., Fauci, A.D., Hauser, S.L., Longo, D.L. and Jameson, J.L. (eds), Harrison's Principles of Internal Medicine., 16 edn. McGraw Hill, NY.
2. Willer, C.J., Dyment, D.A., Risch, N.J., Sadovnick, A.D. and Ebers, G.C. (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl Acad. Sci., 100, 12877-12882.
3. Nielsen, N.M., Westergaard, T., Rostgaard, K., Frisch, M., Hjalgrim, H., Wohlfahrt, J., Koch-Henriksen, N. and Melbye, M. (2005) Familial risk of multiple sclerosis: a nationwide cohort study. Am. J. Epidemiol., 162, 774-778.
4. Hemminki, K., Li, X., Johansson, S.E., Sundquist, K. and Sundquist, J. (2006) Re: 'Familial risk of multiple sclerosis: a nationwide cohort study'. Am. J. Epidemiol., 163, 873-874.
5. Barcellos, L.F., Oksenberg, J.R., Begovich, A.B., Martin, E.R., Schmidt, S., Vittinghoff, E., Goodin, D.S., Pelletier, D., Lincoln, R.R., Bucher, P. et al. (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet., 72, 710-716.
6. Lincoln, M.R., Montpetit, A., Cader, M.Z., Saarela, J., Dyment, D.A., Tiislar, M., Ferretti, V., Tienari, P.J., Sadovnick, A.D., Peltonen, L. et al. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat. Genet., 37, 1108-1112.
7. Oksenberg, J.R., Barcellos, L.F., Cree, B.A.C., Baranzini, S.E., Bugawan, T.L., Khan, O., Lincoln, R.R., Swerdlin, A., Mignot, E., Lin, L. et al. (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am. J. Hum. Genet., 74, 160-167.
8. Barcellos, L.F., Sawcer, S., Ramsay, P.P., Baranzini, S.E., Thomson, G., Briggs, F., Cree, B.C.A., Begovich, A.B., Villoslada, P., Montalban, X. et al. (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet., 15, 2813-2824.
9. Fugger, L. (2000) Human autoimmunity genes in mice. Curr. Opin. Immunol., 12, 698-703.
10. Kaushansky, N., Altmann, D.M., Ascough, S., David, C.S., Lassmann, H. and Ben-Nun, A. (2009) HLA-DQB1*0602 determines disease susceptibility in a new 'humanized' multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. J. Immunol., 183, 3531-3541.
11. Haines, J.L., Ter-Minassian, M., Bazyk, A., Gusella, J.F., Kim, D.J., Terwedow, H., Pericak-Vance, M.A., Rimmler, J.B., Haynes, C.S., Roses, A.D. et al. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat. Genet., 13, 469-471.
12. Sawcer, S., Jones, H.B., Feakes, R., Gray, J., Smaldon, N., Chataway, J., Robertson, N., Clayton, D., Goodfellow, P.N. and Compston, A. (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet., 13, 464-468.
13. Ebers, G.C., Kukay, K., Bulman, D.E., Sadovnick, A.D., Rice, G., Anderson, C., Armstrong, H., Cousin, K., Bell, R.B., Hader, W. et al. (1996) A full genome search in multiple sclerosis. Nat. Genet., 13, 472-476.
14. Sawcer, S., Ban, M., Maranian, M., Yeo, T.W., Compston, A., Kirby, A., Daly, M.J.,De Jager, P.L., Walsh, E., Lander, E.S. et al. (2005) A high-density screen for linkage in multiple sclerosis. Am. J. Hum. Genet., 77, 454-467.
15. Perera, D., Stankovich, J., Butzkueven, H., Taylor, B.V., Foote, S.J., Kilpatrick, T.J. and Rubio, J.P. (2009) Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus. J. Neuroimmunol., 211, 105-109.
16. Hafler, D.A., Compston, A., Sawcer, S., Lander, E.S., Daly, M.J., De Jager, P.L., de Bakker, P.I., Gabriel, S.B., Mirel, D.B., Ivinson, A.J. et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med., 357, 851-862.
17. (2008) Refining genetic associations in multiple sclerosis. Lancet Neurol., 7, 567-569.
18. Rubio, J.P., Stankovich, J., Field, J., Tubridy, N., Marriott, M., Chapman, C., Bahlo, M., Perera, D., Johnson, L.J., Tait, B.D. et al. (2008) Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun., 9, 624-630.
19. De Jager, P.L., Baecher-Allan, C., Maier, L.M., Arthur, A.T., Ottoboni, L., Barcellos, L., McCauley, J.L., Sawcer, S., Goris, A., Saarela, J. et al. (2009) The role of the CD58 locus in multiple sclerosis. Proc. Natl Acad. Sci., 106, 5264-5269.
20. De Jager, P.L., Jia, X., Wang, J., de Bakker, P.I.W., Ottoboni, L., Aggarwal, N.T., Piccio, L., Raychaudhuri, S., Tran, D., Aubin, C. et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet., 41, 776-782.
21. Altshuler, D., Daly, M.J. and Lander, E.S. (2008) Genetic mapping in human disease. Science, 322, 881-888.
22. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
23. Hakonarson, H., Grant, S.F.A., Bradfield, J.P., Marchand, L., Kim, C.E., Glessner, J.T., Grabs, R., Casalunovo, T., Taback, S.P., Frackelton, E.C. et al. (2007) A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature, 448, 591-594.
24. Todd, J.A., Walker, N.M., Cooper, J.D., Smyth, D.J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., Field, S.F., Payne, F. et al. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet., 39, 857-864.
25. Chang, C.H. and Flavell, R.A. (1995) Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med., 181, 765-767.
26. Chang, C.H., Guerder, S., Hong, S.C., van Ewijk, W. and Flavell, R.A. (1996) Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity, 4, 167-178.
27. Kern, I., Steimle, V., Siegrist, C.A. and Mach, B. (1995) The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol., 7, 1295-1299.
28. LeibundGut-Landmann, S., Waldburger, J.M., Krawczyk, M., Otten, L.A., Suter, T., Fontana, A., Acha-Orbea, H. and Reith, W. (2004) Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol., 34, 1513-1525.
29. Muhlethaler-Mottet, A., Otten, L.A., Steimle, V. and Mach, B. (1997) Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J., 16, 2851-2860.
30. Hughes, A. (2006) Evolutionary relationships of vertebrate NACHT domain-containing proteins. Immunogenetics, 58, 785-791.
31. Roy, N., Mahadevan, M.S., McLean, M., Shutler, G., Yaraghi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X. et al. (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell, 80, 167-178.
32. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606.
33. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
34. Steimle, V., Otten, L.A., Zufferey, M. and Mach, B. (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell, 75, 135-146.
35. Rasmussen, H.B., Kelly, M.A. and Clausen, J. (2001) Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3′ untranslated region of the major histocompatibility complex class II transactivator gene. Hum. Immunol., 62, 371-377.
36. Patarroyo, J.C., Stuve, O., Piskurich, J.F., Hauser, S.L., Oksenberg, J.R. and Zamvil, S.S. (2002) Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA). Genes Immunol., 3, 34-37.
37. Swanberg, M., Lidman, O., Padyukov, L., Eriksson, P., Akesson, E., Jagodic, M., Lobell, A., Khademi, M., Borjesson, O., Lindgren, C.M. et al. (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet., 37, 486-494.
38. Bronson, P.G., Criswell, L.A. and Barcellos, L.F. (2008) The MHC2TA 2168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann. Rheum. Dis., 67, 933-936.
39. Akkad, D.A., Jagiello, P., Szyld, P., Goedde, R., Wieczorek, S., Gross, W.L. and Epplen, J.T. (2006) Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int. J. Immunogenet., 33, 59-61.
40. Martinez, A., Sanchez-Lopez, M., Varade, J., Mas, A., Martin, M.C., Heras, V.D.L., Arroyo, R., Mendoza, J.L., Diaz-Rubio, M., Fernandez-Gutierrez, B. et al. (2007) Role of the MHC2TA gene in autoimmune diseases. Ann. Rheum. Dis., 66, 325-329.
41. O'Doherty, C., Hawkins, S., Rooney, M. and Vandenbroeck, K. (2007) The MHC2TA 2168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies. Tissue Antigens, 70, 247-251.
42. Ng, P.C. and Henikoff, S. (2001) Predicting deleterious amino acid substitutions. Genome Res., 11, 863-874.
43. Martinez, A., Alvarez-Lafuente, R., Mas, A., Bartolome, M., Garcia-Montojo, M., de Las Heras, V., de la Concha, E.G., Arroyo, R. and Urcelay, E. (2007) Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA. Hum. Immunol., 68, 685-689.
44. Alvarez-Lafuente, R., Martinez, A., Garcia-Montojo, M., Mas, A., De Las Heras, V., Dominguez-Mozo, M.I., Maria Del Carmen, C., Lopez-Cavanillas, M., Bartolome, M., Gomez de la Concha, E. et al. (2009) MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients. Eur. J. Neurol., 17, 129-135.
45. Harnesk, K., Swanberg, M., Ockinger, J., Diez, M., Lidman, O., Wallstrom, E., Lobell, A., Olsson, T. and Piehl, F. (2008) Vra4 Congenic rats with allelic differences in the class II transactivator gene display altered susceptibility to experimental autoimmune encephalomyelitis. J. Immunol., 180, 3289-3296.
46. Price, A.L., Butler, J., Patterson, N., Capelli, C., Pascali, V.L., Scarnicci, F., Ruiz-Linares, A., Groop, L., Saetta, A.A., Korkolopoulou, P. et al. (2008) Discerning the ancestry of European Americans in genetic association studies. PLoS Genet., 4, e236.
47. ANZgene (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet., 41, 824-828.
48. Baranzini, S.E., Wang, J., Gibson, R.A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.W., Lindberg, R.L., Uitdehaag, B.M., Johnson, M.R. et al. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet., 18, 767-778.
49. (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
50. Polman, C.H., Reingold, S.C., Edan, G., Filippi, M., Hartung, H.P., Kappos, L., Lublin, F.D., Metz, L.M., McFarland, H.F., O'Connor, P.W. et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann. Neurol., 58, 840-846.
51. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
52. Wigginton, J.E., Cutler, D.J. and Abecasis, G.R. (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet., 76, 887-893.
53. O'Connell, J.R. and Weeks, D.E. (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet., 63, 259-266.
54. Wigginton, J.E. and Abecasis, G.R. (2005) PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics, 21, 3445-3447.
55. Caillier, S.J., Briggs, F., Cree, B.A., Baranzini, S.E., Fernandez-Vina, M., Ramsay, P.P., Khan, O., Royal, W. 3rd, Hauser, S.L., Barcellos, L.F. et al. (2008) Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J. Immunol., 181, 5473-5480.
56. Falush, D., Stephens, M. and Pritchard, J.K. (2003) Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics, 164, 1567-1587.
57. Cochran, W.G. (1954) Some methods for strengthening the comon X2 tests. Biometrics, 10, 417-451.
58. Armitage, P. (1955) Tests for linear trends in proportions and frequencies. Biometrics, 11, 375-386.
59. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. B Met., 57, 289-300.
60. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
61. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.
62. Spielman, R.S., McGinnis, R.E. and Ewens, W.J. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet., 52, 506-516.
63. Martin, E.R., Monks, S.A., Warren, L.L. and Kaplan, N.L. (2000) A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am. J. Hum. Genet., 67, 146-154.
64. Thomson, G. (1995) Mapping disease genes: family-based association studies. Am. J. Hum. Genet., 57, 487-498.
65. Mantel, N. and Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst., 22, 719-748.
66. Spielman, R.S. and Ewens, W.J. (1998) A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am. J. Hum. Genet., 62,450-458.
67. Purcell, S., Sham, P. and Daly, M.J. (2005) Parental phenotypes in family-based association analysis. Am. J. Hum. Genet., 76, 249-259.
68. Self, S.G., Longton, G., Kopecky, K.J. and Liang, K.Y. (1991) On estimating HLA/disease association with application to a study of aplastic anemia. Biometrics, 47, 53-61.
69. Schaid, D.J. (1996) General score tests for associations of genetic markers with disease using cases and their parents. Genet. Epidemiol., 13, 423-449.
70. Cordell, H.J. and Clayton, D.G. (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet., 70, 124-141.
71. Yang, Q., Khoury, M.J., Sun, F. and Flanders, W.D. (1999) Case-only design to measure gene-gene interaction. Epidemiology, 10, 167-170.
72. Clarke, G.M., Pettersson, F.H. and Morris, A.P. (2009) A comparison of case-only designs for detecting gene x gene interaction in rheumatoid arthritis using genome-wide case-control data in Genetic Analysis Workshop 16. BMC Proc., 3 (Suppl. 7), S73.
73. Thomson, G. and Valdes, A.M. (2007) Conditional genotype analysis: detecting secondary disease loci in linkage disequilibrium with a primary disease locus. BMC Proc., 1 (Suppl. 1), S163.
74. Menashe, I., Rosenberg, P.S. and Chen, B.E. (2008) PGA: power calculator for case-control genetic association analyses. BMC Genet., 9,36.
75. DerSimonian, R. and Laird, N. (1986) Meta-analysis in clinical trials. Control. Clin. Trials, 7, 177-188.
76. de Bakker, P.I., McVean, G., Sabeti, P.C., Miretti, M.M., Green, T., Marchini, J., Ke, X., Monsuur, A.J., Whittaker, P., Delgado, M. et al. (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet., 38, 1166-1172.